You are viewing the site in preview mode

Skip to main content

Advertisement

Figure 1 | BMC Infectious Diseases

Figure 1

From: Extended antigen sparing potential of AS03-adjuvanted pandemic H1N1 vaccines in children, and immunological equivalence of two formulations of AS03-adjuvanted H1N1 vaccines: results from two randomised trials

Figure 1

Subject flow through the studies. (A) Study in adults: reasons for elimination from the ATP immunogenicity and persistence cohorts were: non-compliance with vaccination/blood sampling schedule; blood sample not taken/insufficient quantity for any test; randomisation failure; received a vaccine forbidden by the protocol. (B) Study in children: reasons for elimination from the ATP persistence cohort were: received medication forbidden per protocol; blood sample not taken or quantity not sufficient for any test.

Back to article page